Marshall Wace, LLP Smith & Nephew PLC Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Smith & Nephew PLC stock. As of the latest transaction made, Marshall Wace, LLP holds 28,762 shares of SNN stock, worth $813,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,762

Holding current value

$813,676

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$25.36 - $28.88 $729,404 - $830,646	28,762 New	28,762 $729,000
Q2 2023 Aug 14, 2023	BUY	$28.08 - $32.7 $704,134 - $819,985	25,076 New	25,076 $808,000
Q3 2022 Nov 14, 2022	SELL	$12.1 - $29.35 $702,308 - $1.7 Million	-58,042 Reduced 55.63%	46,286 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$27.53 - $33.71 $5.69 Million - $6.97 Million	-206,728 Reduced 66.46%	104,328 $2.91 Million
Q1 2022 May 16, 2022	BUY	$30.84 - $36.38 $2.73 Million - $3.22 Million	88,374 Added 39.69%	311,056 $9.92 Million

Q4 2021 Feb 14, 2022	SELL	$31.98 - $37.15 $2.78 Million - $3.23 Million	-86,999 Reduced 28.09%	222,682 $7.71 Million
Q3 2021 Nov 15, 2021	BUY	$34.34 - $44.17 $566,335 - $728,451	16,492 Added 5.63%	309,681 $10.6 Million
Q2 2021 Aug 13, 2021	BUY	$37.86 - $44.01 $10.7 Million - $12.4 Million	281,452 Added 2397.99%	293,189 $12.7 Million
Q1 2021 May 17, 2021	BUY	$36.75 - $45.88 $431,334 - $538,493	11,737 New	11,737 $444,000
Q4 2018 Feb 14, 2019	SELL	$32.4 - $38.6 $618,872 - $737,298	-19,101 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$35.11 - $37.52 $670,636 - $716,669	19,101 New	19,101 $708,000

Others Institutions Holding SNN

# of Institutions

222

Shares Held

31.5M

Call Options Held

2.8K

Put Options Held

51.7K

View Full List

About SMITH & NEPHEW PLC

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $12.3B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

More about SNN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account